Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5000 participants.
Also called NCT04684602
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 5,000 participants
- Sponsor
- Thomas Advanced Medical LLC
- Registry
-
NCT04684602
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04684602. Non-randomized; no masking; primary purpose treatment. Start 2020-07-09 (actual); primary completion 2030-07-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Condition
- Autoimmune Diseases
- Condition
- Cardiovascular Disorders
- Condition
- Diabetes Complications
- Condition
- Integumentary Disease
- Condition
- Musculoskeletal Disorders
- Condition
- Neurodegenerative Disorders
- Condition
- Neurologic Disorders
- Condition
- Pulmonary Disorders
- Condition
- Sexual Dysfunction
- Condition
- Urologic Disorders
- Condition
- Viral Illness
- Intervention (Biological)
- PrimePro™/ PrimeMSK™
- Lead sponsor
- Thomas Advanced Medical LLC
- Collaborator
- HeartStem Institute
- Collaborator
- NuStem
Record details
- Record id
cardio:ct-nct04684602- Content hash
3024a772a7ebfdd4019789e8db57050a6fd249946d5e83a55299e9c3eb53acde